Comment on CMS-2026-2212-0001
UnitedHealth GroupSupportBusiness
Summary: Optum Rx (a subsidiary of UnitedHealth Group) supports the CMS Request for Information regarding PBM provisions in the Consolidated Appropriations Act of 2026. They argue that CMS should adhere strictly to statutory boundaries, preserve market-based competition, and ensure that new regulations are operationally feasible and harmonized with existing Medicare frameworks to avoid unintended cost increases.
UnitedHealth Group is pleased to submit comments on this Request for Information. Please see attached for our response.